U.S. listings by Chinese firms face mounting challenges on both sides of Pacific
While new Nasdaq rules threaten to derail many smaller U.S. listings by Chinese companies, China’s securities regulator is also stepping up its scrutiny of such listings Key Takeaways: China’s securities…
Its Hong Kong listing advancing, will investors drink up Bama Tea shares?
After three failed listing attempts, the tea leaf seller has received a key regulatory green light for its planned IPO from China’s securities watchdog Key Takeaways: Bama Teach has been…
BRIEF: CATL gets Chinese regulatory nod for Hong Kong listing
Leading electric-vehicle (EV) battery maker Contemporary Amperex Technology Co. (300750.SZ), or CATL, received a listing approval notice from the China Securities Regulatory Commission (CSRC) on Tuesday — a necessary step…
BRIEF: Qyuns Therapeutics secures CSRC approval for full H-share circulation
Biopharmaceutical company Qyuns Therapeutics Co. Ltd. (2509.HK) announced on Tuesday that the China Securities Regulatory Commission (CSRC) has approved its plan to convert 17.32 million of its domestic shares into…
BRIEF: Coland Ocean secures CSRC approval for Hong Kong IPO
Fish oil products maker Coland Ocean Group Ltd. received a listing approval notice from the China Securities Regulatory Commission (CSRC) on Thursday, a required step for all Chinese companies seeking…
BRIEF: Ascentage Pharma gets Chinese regulatory nod for U.S. listing
Biopharmaceutical company Ascentage Pharma Group International (6855.HK) received a listing approval notice from the China Securities Regulatory Commission (CSRC) on Monday, a necessary step before it can make an overseas…
BRIEF: Rimag Group secures CSRC approval for full circulation of H-Shares
Medical imaging services provider Jiangxi Rimag Group Co. Ltd. (2522.HK) announced on Wednesday that the China Securities Regulatory Commission (CSRC) has approved its plan to convert 51.562 million of its…
